Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 788.00
+21.00 (2.74%)
Oct 26, 2026, 3:30 PM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.03 billion as of October 26, 2026. It is the 35,197th most valuable company in the world and the 3,268th biggest in Japan. Its market cap has decreased by 49.19% in one year.
Market Cap
4.03B
Enterprise Value
3.48B
Revenue
4.69B
Global Rank
Country Rank
#3,268 Japan
PE Ratio
31.47
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.03B, a decrease of -66.11%. That is a compound annual growth rate of -35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 4.03B | -47.08% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.63B |
| BrightPath Biotherapeutics | 5.56B |
| Kringle Pharma | 5.00B |
| PRISM BioLab Co.,LTD | 4.95B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.78B |
| Ribomic | 3.68B |
| Transgenic Group | 3.63B |